 |
 Previous Article | Next Article 
Journal of Neuroscience, Vol 16, 65-70, Copyright © 1996 by Society for Neuroscience
11 beta-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity
V Rajan, CR Edwards and JR Seckl
Edinburgh University, Department of Medicine, Western General Hospital, United Kingdom.
11 beta-Hydroxysteroid dehydrogenase (11 beta-HSD) catalyzes the conversion
of the glucocorticoid corticosterone (cortisol in humans) to inert
11-dehydrocorticosterone (cortisone). 11 beta-HSD activity is present in
the hippocampus, where it is induced by glucocorticoids and stress in vivo,
prompting suggestions that the enzyme may attenuate the deleterious effects
of chronic glucocorticoid excess on neuronal function and survival. Two
isoforms exist: 11 beta-HSD1, a bidirectional NADPH-dependent enzyme, and
11 beta-HSD2, an NAD(+)- dependent exclusive 11 beta-dehydrogenase
(corticosterone-inactivating enzyme). In this study, 11 beta-HSD1 activity
and mRNA synthesis were demonstrated in primary fetal hippocampal cell
cultures. Unexpectedly, the reaction direction in intact hippocampal cells
was 11 beta- reduction (reactivation of inert 11-dehydrocorticosterone),
although homogenization revealed that the enzyme was capable of 11 beta-
dehydrogenation when removed from its normal cellular context.
Dexamethasone (10(-7) M) increased 11 beta-HSD activity in homogenates of
hippocampal cultures (102% increase). In intact hippocampal cells,
dexamethasone induced 11 beta reductase, not dehydrogenase. To determine
the functional relevance of hippocampal 11 beta-reductase, glucocorticoid
potentiation of kainic acid neurotoxicity was examined. Pretreatment of
hippocampal cells with corticosterone reduced survival on kainate exposure.
Hippocampal cell 11 beta-HSD activity was potently inhibited by
carbenoxolone. Carbenoxolone had no effect on cell survival after kainate
alone and did not alter the effect of corticosterone.
11-Dehydrocorticosterone also potentiated kainate neurotoxicity; this
effect was lost, however, if 11 beta-HSD was inhibited with carbenoxolone.
Thus, hippocampal 11 beta-HSD seems to be a functional 11 beta-reductase in
intact cells. Measures to attenuate hippocampal 11 beta-reductase may
reduce neuronal vulnerability to glucocorticoid toxicity.
This article has been cited by other articles:
|
|
|
|
 
J. C. Geerling and A. D. Loewy
Aldosterone in the brain
Am J Physiol Renal Physiol,
September 1, 2009;
297(3):
F559 - F576.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. W. Yau, K. M. McNair, J. Noble, D. Brownstein, C. Hibberd, N. Morton, J. J. Mullins, R. G. M. Morris, S. Cobb, and J. R. Seckl
Enhanced Hippocampal Long-Term Potentiation and Spatial Learning in Aged 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Knock-Out Mice
J. Neurosci.,
September 26, 2007;
27(39):
10487 - 10496.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. S. Densmore, N. M. Morton, J. J. Mullins, and J. R. Seckl
11{beta}-Hydroxysteroid Dehydrogenase Type 1 Induction in the Arcuate Nucleus by High-Fat Feeding: A Novel Constraint to Hyperphagia?
Endocrinology,
September 1, 2006;
147(9):
4486 - 4495.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Shoener, R. Baig, and K. C. Page
Prenatal exposure to dexamethasone alters hippocampal drive on hypothalamic-pituitary-adrenal axis activity in adult male rats
Am J Physiol Regulatory Integrative Comp Physiol,
May 1, 2006;
290(5):
R1366 - R1373.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Draper and P. M Stewart
11{beta}-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
J. Endocrinol.,
August 1, 2005;
186(2):
251 - 271.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. G. Smith, L. Betancourt, and Y. Sun
Molecular Endocrinology and Physiology of the Aging Central Nervous System
Endocr. Rev.,
April 1, 2005;
26(2):
203 - 250.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Liu, Y. Nakagawa, Y. Wang, R. Sakurai, P. V. Tripathi, K. Lutfy, and T. C. Friedman
Increased Glucocorticoid Receptor and 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression in Hepatocytes May Contribute to the Phenotype of Type 2 Diabetes in db/db Mice
Diabetes,
January 1, 2005;
54(1):
32 - 40.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W. Tomlinson, E. A. Walker, I. J. Bujalska, N. Draper, G. G. Lavery, M. S. Cooper, M. Hewison, and P. M. Stewart
11{beta}-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response
Endocr. Rev.,
October 1, 2004;
25(5):
831 - 866.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. C. Sandeep, J. L. W. Yau, A. M. J. MacLullich, J. Noble, I. J. Deary, B. R. Walker, and J. R. Seckl
From The Cover: 11{beta}-Hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics
PNAS,
April 27, 2004;
101(17):
6734 - 6739.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker
Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Recent Prog. Horm. Res.,
January 1, 2004;
59(1):
359 - 393.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. J.-F. de Quervain, R. Poirier, M. A. Wollmer, L. M.E. Grimaldi, M. Tsolaki, J. R. Streffer, C. Hock, R. M. Nitsch, M. H. Mohajeri, and A. Papassotiropoulos
Glucocorticoid-related genetic susceptibility for Alzheimer's disease
Hum. Mol. Genet.,
January 1, 2004;
13(1):
47 - 52.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Sun and L. Myatt
Enhancement of Glucocorticoid-Induced 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression by Proinflammatory Cytokines in Cultured Human Amnion Fibroblasts
Endocrinology,
December 1, 2003;
144(12):
5568 - 5577.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Liu, Y. Nakagawa, Y. Wang, R. Li, X. Li, T. Ohzeki, and T. C. Friedman
Leptin Activation of Corticosterone Production in Hepatocytes May Contribute to the Reversal of Obesity and Hyperglycemia in Leptin-Deficient ob/ob Mice
Diabetes,
June 1, 2003;
52(6):
1409 - 1416.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Shafqat, B. Elleby, S. Svensson, J. Shafqat, H. Jornvall, L. Abrahmsen, and U. Oppermann
Comparative Enzymology of 11beta -Hydroxysteroid Dehydrogenase Type 1 from Glucocorticoid Resistant (Guinea Pig) Versus Sensitive (Human) Species
J. Biol. Chem.,
January 10, 2003;
278(3):
2030 - 2035.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. C. Andrews, O. Rooyackers, and B. R. Walker
Effects of the 11{beta}-Hydroxysteroid Dehydrogenase Inhibitor Carbenoxolone on Insulin Sensitivity in Men with Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
January 1, 2003;
88(1):
285 - 291.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Sun, P. He, and K. Yang
Intracrine Induction of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression by Glucocorticoid Potentiates Prostaglandin Production in the Human Chorionic Trophoblast
Biol Reprod,
November 1, 2002;
67(5):
1450 - 1455.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Korbonits, I. Bujalska, M. Shimojo, J. Nobes, S. Jordan, A. B. Grossman, and P. M. Stewart
Expression of 11{beta}-Hydroxysteroid Dehydrogenase Isoenzymes in the Human Pituitary: Induction of the Type 2 Enzyme in Corticotropinomas and Other Pituitary Tumors
J. Clin. Endocrinol. Metab.,
June 1, 2001;
86(6):
2728 - 2733.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Seckl and B. R. Walker
Minireview: 11{beta}-Hydroxysteroid Dehydrogenase Type 1-- A Tissue-Specific Amplifier of Glucocorticoid Action
Endocrinology,
April 1, 2001;
142(4):
1371 - 1376.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. L. W. Yau, J. Noble, C. J. Kenyon, C. Hibberd, Y. Kotelevtsev, J. J. Mullins, and J. R. Seckl
Lack of tissue glucocorticoid reactivation in 11beta -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments
PNAS,
March 22, 2001;
(2001)
71562698.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
H. J. Harris, Y. Kotelevtsev, J. J. Mullins, J. R. Seckl, and M. C. Holmes
Intracellular Regeneration of Glucocorticoids by 11{beta}-Hydroxysteroid Dehydrogenase (11{beta}-HSD)-1 Plays a Key Role in Regulation of the Hypothalamic-Pituitary-Adrenal Axis: Analysis of 11{beta}-HSD-1-Deficient Mice
Endocrinology,
January 1, 2001;
142(1):
114 - 120.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Lloyd-MacGilp, S. M. Nelson, M. Florin, M. Lo, J. McKinnell, J. Sassard, and C. J. Kenyon
11{beta}-Hydroxysteroid Dehydrogenase and Corticosteroid Action in Lyon Hypertensive Rats
Hypertension,
November 1, 1999;
34(5):
1123 - 1128.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Jamieson, A. M. Wallace, R. Andrew, B. S. Nunez, B. R. Walker, R. Fraser, P. C. White, and J. M. C. Connell
Apparent Cortisone Reductase Deficiency: A Functional Defect in 11{beta}-Hydroxysteroid Dehydrogenase Type 1
J. Clin. Endocrinol. Metab.,
October 1, 1999;
84(10):
3570 - 3574.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. J. Bujalska, S. Kumar, M. Hewison, and P. M. Stewart
Differentiation of Adipose Stromal Cells: The Roles of Glucocorticoids and 11{beta}-Hydroxysteroid Dehydrogenase
Endocrinology,
July 1, 1999;
140(7):
3188 - 3196.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
P. M. Stewart, A. Boulton, S. Kumar, P. M. S. Clark, and C. H. L. Shackleton
Cortisol Metabolism in Human Obesity: Impaired Cortisone->Cortisol Conversion in Subjects with Central Adiposity
J. Clin. Endocrinol. Metab.,
March 1, 1999;
84(3):
1022 - 1027.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. P Gardner and L. Zhang
Glucocorticoid modulation of Ca2+ homeostasis in human B lymphoblasts
J. Physiol.,
January 15, 1999;
514(2):
385 - 396.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. R. de Kloet, E. Vreugdenhil, M. S. Oitzl, and M. Joëls
Brain Corticosteroid Receptor Balance in Health and Disease
Endocr. Rev.,
June 1, 1998;
19(3):
269 - 301.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. L. Ricketts, J. M. Verhaeg, I. Bujalska, A. J. Howie, W. E. Rainey, and P. M. Stewart
Immunohistochemical Localization of Type 1 11{beta}-Hydroxysteroid Dehydrogenase in Human Tissues
J. Clin. Endocrinol. Metab.,
April 1, 1998;
83(4):
1325 - 1335.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
R. Diaz, R. W. Brown, and J. R. Seckl
Distinct Ontogeny of Glucocorticoid and Mineralocorticoid Receptor and 11beta -Hydroxysteroid Dehydrogenase Types I and II mRNAs in the Fetal Rat Brain Suggest a Complex Control of Glucocorticoid Actions
J. Neurosci.,
April 1, 1998;
18(7):
2570 - 2580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Kotelevtsev, M. C. Holmes, A. Burchell, P. M. Houston, D. Schmoll, P. Jamieson, R. Best, R. Brown, C. R. W. Edwards, J. R. Seckl, et al.
11beta -Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress
PNAS,
December 23, 1997;
94(26):
14924 - 14929.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R.-S. Ge, H.-B. Gao, V. L. Nacharaju, G. L. Gunsalus, and M. P. Hardy
Identification of a Kinetically Distinct Activity of 11{beta}-Hydroxysteroid Dehydrogenase in Rat Leydig Cells
Endocrinology,
June 1, 1997;
138(6):
2435 - 2442.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. A. Rose, G. Stapleton, K. Dott, M. P. Kieny, R. Best, M. Schwarz, D. W. Russell, I. Bjorkhem, J. Seckl, and R. Lathe
Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7alpha -hydroxy dehydroepiandrosterone and 7alpha -hydroxy pregnenolone
PNAS,
May 13, 1997;
94(10):
4925 - 4930.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. C. White, T. Mune, and A. K. Agarwal
11{beta}-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess
Endocr. Rev.,
February 1, 1997;
18(1):
135 - 156.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
H.-B. Gao, R.-S. Ge, V. Lakshmi, A. Marandici, and M. P. Hardy
Hormonal Regulation of Oxidative and Reductive Activities of 11{beta}-Hydroxysteroid Dehydrogenase in Rat Leydig Cells
Endocrinology,
January 1, 1997;
138(1):
156 - 161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. A. Walker, A. M. Clark, M. Hewison, J. P. Ride, and P. M. Stewart
Functional Expression, Characterization, and Purification of the Catalytic Domain of Human 11-beta -Hydroxysteroid Dehydrogenase Type 1
J. Biol. Chem.,
June 8, 2001;
276(24):
21343 - 21350.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. M. Morton, M. C. Holmes, C. Fievet, B. Staels, A. Tailleux, J. J. Mullins, and J. R. Seckl
Improved Lipid and Lipoprotein Profile, Hepatic Insulin Sensitivity, and Glucose Tolerance in 11beta -Hydroxysteroid Dehydrogenase Type 1 Null Mice
J. Biol. Chem.,
October 26, 2001;
276(44):
41293 - 41300.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. W. Yau, J. Noble, C. J. Kenyon, C. Hibberd, Y. Kotelevtsev, J. J. Mullins, and J. R. Seckl
Lack of tissue glucocorticoid reactivation in 11beta -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments
PNAS,
April 10, 2001;
98(8):
4716 - 4721.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Hanafusa, T. Mune, T. Tanahashi, Y. Isomura, T. Suwa, M. Isaji, H. Daido, H. Morita, M. Murayama, and K. Yasuda
Altered corticosteroid metabolism differentially affects pituitary corticotropin response
Am J Physiol Endocrinol Metab,
February 1, 2002;
282(2):
E466 - E473.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
